首页 > 最新文献

Colorectal Disease最新文献

英文 中文
Complex anal fistulas and laser therapy: A critical appraisal of the FISTULASER study 复杂肛瘘和激光治疗:对瘘管激光研究的关键评价。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-09 DOI: 10.1111/codi.70343
Vipul D. Yagnik, Pankaj Garg, Kaushik Bhattacharya
{"title":"Complex anal fistulas and laser therapy: A critical appraisal of the FISTULASER study","authors":"Vipul D. Yagnik, Pankaj Garg, Kaushik Bhattacharya","doi":"10.1111/codi.70343","DOIUrl":"10.1111/codi.70343","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is self-reported recurrent urinary tract infection associated with anal incontinence and obstructive defecation? A multicentre case-control study using electronic PROM data 自我报告的复发性尿路感染与肛门失禁和排便障碍有关吗?使用电子PROM数据的多中心病例对照研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-09 DOI: 10.1111/codi.70336
Thomas J. Curtis, Roberta Bugeja, Stephen C. Radley, Thomas G. Gray

Aim

The accepted model for the pathogenesis of female urinary tract infection (UTI) is ascending infection with bowel flora from anus to urethra, though anal incontinence (AI) and obstructive defecation (ODS) have not previously been demonstrated to be risk factors for recurrent UTI (rUTI). This study aimed to use patient-reported outcome (PROM) data to investigate the association between AI and ODS with self-reported rUTI in women.

Method

Data obtained from 7990 completed ePAQ-Pelvic Floor PROMs at seven participating NHS hospitals between 2018 and 2022 were analysed. Essential inclusion criteria were completion of both the bowel dimension and item assessing self-reported rUTI in consenting participants. Participants were divided into cases and controls based on self-reported frequency of UTI. Mann–Whitney, logistic regression and Spearman's rank analyses were performed to assess for associations between self-reported rUTI with AI and ODS.

Results

rUTI was reported by 931 women (11.7%). Significantly worse symptom scores for flatus incontinence (p < 0.0001) (OR 1.24), liquid AI (p < 0.0001) (OR 1.38), solid AI (p = 0.0031) (OR 1.24), passive faecal incontinence (p < 0.0001) (OR 1.40), use of pads for AI (p < 0.0001) (OR 1.34), perineal splinting/vaginal digitation (p < 0.0001) (OR 1.19) and anal digitation (p < 0.0001) (OR 1.30) were reported in participants with rUTI. Frequency of UTI weakly correlated with all AI and ODS symptoms (r = 0.069–0.151, p < 0.0001).

Conclusion

AI and ODS symptoms are significantly associated with increased rates of self-reported rUTI in this study, supporting the theory that these conditions may contribute to the pathogenesis of rUTI in women. Whilst the aetiology of rUTI is multifactorial, AI and ODS are contributory risk factors.

目的:女性尿路感染(UTI)发病机制的公认模型是从肛门到尿道的肠道菌群上行感染,尽管肛门失禁(AI)和排便梗阻(ODS)先前并未被证明是复发性尿路感染(rUTI)的危险因素。本研究旨在使用患者报告的结果(PROM)数据来调查AI和ODS与女性自我报告的rUTI之间的关系。方法:对2018年至2022年7家NHS参与医院7990例epaq -盆底PROMs数据进行分析。基本的纳入标准是在同意的参与者中完成肠道尺寸和自我报告的rUTI项目评估。参与者根据自我报告的尿路感染频率分为病例和对照组。采用Mann-Whitney、logistic回归和Spearman等级分析来评估自我报告的rUTI与AI和ODS之间的关联。结果:931例(11.7%)女性报告rUTI。结论:在本研究中,AI和ODS症状与自我报告rUTI发生率的增加显著相关,支持了这些条件可能与女性rUTI发病机制有关的理论。虽然rUTI的病因是多因素的,但AI和ODS是促成风险因素。
{"title":"Is self-reported recurrent urinary tract infection associated with anal incontinence and obstructive defecation? A multicentre case-control study using electronic PROM data","authors":"Thomas J. Curtis,&nbsp;Roberta Bugeja,&nbsp;Stephen C. Radley,&nbsp;Thomas G. Gray","doi":"10.1111/codi.70336","DOIUrl":"10.1111/codi.70336","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The accepted model for the pathogenesis of female urinary tract infection (UTI) is ascending infection with bowel flora from anus to urethra, though anal incontinence (AI) and obstructive defecation (ODS) have not previously been demonstrated to be risk factors for recurrent UTI (rUTI). This study aimed to use patient-reported outcome (PROM) data to investigate the association between AI and ODS with self-reported rUTI in women.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Data obtained from 7990 completed ePAQ-Pelvic Floor PROMs at seven participating NHS hospitals between 2018 and 2022 were analysed. Essential inclusion criteria were completion of both the bowel dimension and item assessing self-reported rUTI in consenting participants. Participants were divided into cases and controls based on self-reported frequency of UTI. Mann–Whitney, logistic regression and Spearman's rank analyses were performed to assess for associations between self-reported rUTI with AI and ODS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>rUTI was reported by 931 women (11.7%). Significantly worse symptom scores for flatus incontinence (<i>p</i> &lt; 0.0001) (OR 1.24), liquid AI (<i>p</i> &lt; 0.0001) (OR 1.38), solid AI (<i>p</i> = 0.0031) (OR 1.24), passive faecal incontinence (<i>p</i> &lt; 0.0001) (OR 1.40), use of pads for AI (<i>p</i> &lt; 0.0001) (OR 1.34), perineal splinting/vaginal digitation (<i>p</i> &lt; 0.0001) (OR 1.19) and anal digitation (<i>p</i> &lt; 0.0001) (OR 1.30) were reported in participants with rUTI. Frequency of UTI weakly correlated with all AI and ODS symptoms (<i>r</i> = 0.069–0.151, <i>p</i> &lt; 0.0001).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>AI and ODS symptoms are significantly associated with increased rates of self-reported rUTI in this study, supporting the theory that these conditions may contribute to the pathogenesis of rUTI in women. Whilst the aetiology of rUTI is multifactorial, AI and ODS are contributory risk factors.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fusion surgery for intracorporeal anastomosis in robotic colectomy: A video vignette 融合手术用于机器人结肠切除术的体内吻合:一个视频片段。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-09 DOI: 10.1111/codi.70341
Fumi Hasegawa, Masahiro Fuse, Taku Sato, Taira Inutake, Yuri Kawashima, Megumu Enjoji
{"title":"Fusion surgery for intracorporeal anastomosis in robotic colectomy: A video vignette","authors":"Fumi Hasegawa,&nbsp;Masahiro Fuse,&nbsp;Taku Sato,&nbsp;Taira Inutake,&nbsp;Yuri Kawashima,&nbsp;Megumu Enjoji","doi":"10.1111/codi.70341","DOIUrl":"10.1111/codi.70341","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual health of LGBTQ+ patients undergoing colorectal surgery for benign disease and their experience with healthcare: A scoping review LGBTQ+患者接受结肠直肠良性疾病手术的性健康及其医疗保健经验:范围综述
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-09 DOI: 10.1111/codi.70327
Zoe Marangoni, Louis Onghena, Maddalena Giacomozzi, Yves van Nieuwenhove, Eva Pape, Gabrielle H. van Ramshorst

Introduction

Colorectal surgery for benign indications affects patients' sexual health. LGBTQ+ patients often face discrimination, resulting in unmet health needs. We aimed to investigate how colorectal surgery for benign disease affects LGBTQ+ individuals' sexual health, and which barriers exist to access healthcare.

Methods

PubMed, Embase, Web of Science, Scopus, PsychINFO, Google Scholar, CINHAL, ProQuest, Cochrane library and Joanna Briggs Institute were systematically searched. Screening and data extraction were performed independently by two researchers. Inclusion criteria were adult patients who self-identified as LGBTQ+; colorectal or anal procedures for benign disease; outcomes of sexual health/wellbeing/pleasure. Exclusion criteria were appendicectomy, transrectal procedures or gender-affirming surgery and >50% of patients treated for malignancy.

Results

Of the 719 records, eight articles were selected: one prospective cohort study, three mixed-methods surveys and four literature reviews. Ten main themes were identified: sexual function/activity and pain, anoreceptive intercourse (ARI), sexual satisfaction and pleasure, mental health and body image, obstacles and coping strategies, dating and relationships, partner response and inclusion, experience with healthcare providers, information sources, stigma and discrimination. Colorectal surgery negatively impacts sexual health and relationships. LGBTQ+ patients reported challenges in accessing care and information regarding sexual health after colorectal surgery, whilst facing discrimination and stigma.

Conclusion

Colorectal surgery for benign disease affects LGBTQ+ patients' sexual health. Literature is scarce, with limited data stratification for sexual orientation or gender identity. Healthcare providers need to be educated about LGBTQ+ needs relating to sexual health and surgery, and inclusive clinical guidelines should be developed.

结直肠手术的良性适应症影响患者的性健康。LGBTQ+患者经常面临歧视,导致健康需求得不到满足。我们的目的是调查结肠直肠良性疾病手术如何影响LGBTQ+个体的性健康,以及在获得医疗保健方面存在哪些障碍。方法系统检索PubMed、Embase、Web of Science、Scopus、PsychINFO、谷歌Scholar、CINHAL、ProQuest、Cochrane library和Joanna Briggs Institute。筛选和数据提取由两名研究人员独立完成。纳入标准为自认为LGBTQ+的成年患者;结肠直肠或肛门良性疾病的手术;性健康/幸福/快乐的结果。排除标准为阑尾切除术、经直肠手术或性别确认手术,50%的患者接受过恶性肿瘤治疗。结果共纳入719篇文献,共选择8篇:1篇前瞻性队列研究,3篇混合方法调查,4篇文献综述。确定了十个主题:性功能/活动和疼痛、无接受性性交(ARI)、性满足和愉悦、心理健康和身体形象、障碍和应对策略、约会和关系、伴侣反应和包容、与卫生保健提供者的经验、信息来源、耻辱和歧视。结直肠手术对性健康和两性关系有负面影响。LGBTQ+患者报告说,在结肠直肠癌手术后获得有关性健康的护理和信息方面存在挑战,同时面临歧视和污名。结论结直肠手术治疗良性疾病会影响LGBTQ+患者的性健康。文献很少,关于性取向或性别认同的数据分层有限。医疗保健提供者需要了解LGBTQ+在性健康和手术方面的需求,并应制定包容性的临床指南。
{"title":"Sexual health of LGBTQ+ patients undergoing colorectal surgery for benign disease and their experience with healthcare: A scoping review","authors":"Zoe Marangoni,&nbsp;Louis Onghena,&nbsp;Maddalena Giacomozzi,&nbsp;Yves van Nieuwenhove,&nbsp;Eva Pape,&nbsp;Gabrielle H. van Ramshorst","doi":"10.1111/codi.70327","DOIUrl":"https://doi.org/10.1111/codi.70327","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Colorectal surgery for benign indications affects patients' sexual health. LGBTQ+ patients often face discrimination, resulting in unmet health needs. We aimed to investigate how colorectal surgery for benign disease affects LGBTQ+ individuals' sexual health, and which barriers exist to access healthcare.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>PubMed, Embase, Web of Science, Scopus, PsychINFO, Google Scholar, CINHAL, ProQuest, Cochrane library and Joanna Briggs Institute were systematically searched. Screening and data extraction were performed independently by two researchers. Inclusion criteria were adult patients who self-identified as LGBTQ+; colorectal or anal procedures for benign disease; outcomes of sexual health/wellbeing/pleasure. Exclusion criteria were appendicectomy, transrectal procedures or gender-affirming surgery and &gt;50% of patients treated for malignancy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 719 records, eight articles were selected: one prospective cohort study, three mixed-methods surveys and four literature reviews. Ten main themes were identified: sexual function/activity and pain, anoreceptive intercourse (ARI), sexual satisfaction and pleasure, mental health and body image, obstacles and coping strategies, dating and relationships, partner response and inclusion, experience with healthcare providers, information sources, stigma and discrimination. Colorectal surgery negatively impacts sexual health and relationships. LGBTQ+ patients reported challenges in accessing care and information regarding sexual health after colorectal surgery, whilst facing discrimination and stigma.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Colorectal surgery for benign disease affects LGBTQ+ patients' sexual health. Literature is scarce, with limited data stratification for sexual orientation or gender identity. Healthcare providers need to be educated about LGBTQ+ needs relating to sexual health and surgery, and inclusive clinical guidelines should be developed.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145750874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bowel preserving surgery for stricturing jejunoileal Crohn's disease, part 4: Jaboulay duodenal strictureplasty: A step-by-step video vignette—A video vignette 保留肠手术治疗狭窄的空肠回肠克罗恩病,第4部分:贾布雷十二指肠狭窄置换术:一步一步的视频短片。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-09 DOI: 10.1111/codi.70325
Oscar Hernandez, Stefan D. Holubar, Daniel Joyce, Robert Simon
{"title":"Bowel preserving surgery for stricturing jejunoileal Crohn's disease, part 4: Jaboulay duodenal strictureplasty: A step-by-step video vignette—A video vignette","authors":"Oscar Hernandez,&nbsp;Stefan D. Holubar,&nbsp;Daniel Joyce,&nbsp;Robert Simon","doi":"10.1111/codi.70325","DOIUrl":"10.1111/codi.70325","url":null,"abstract":"","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145713525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of defunctioning ileostomies on postoperative kidney function in rectal cancer surgery 失功能回肠造口术对直肠癌术后肾功能的影响。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-08 DOI: 10.1111/codi.70329
Gustav Sandén, Ida Hed Myrberg, Sol Erika Boman, Caroline Nordenvall, Juan-Jesus Carrero, Peter Matthiessen, Martin Rutegård

Aim

To investigate short- and long-term kidney injury incidence in patients undergoing low anterior resection for rectal cancer, comparing those with and without a defunctioning ileostomy.

Method

We identified all Swedish rectal cancer patients ≤80 years old, with ASA fitness grade ≤III and tumour height ≤12 cm from the anal verge, who underwent anterior resection between 2007 and 2021 using CRCBaSe, a nationwide registry linkage. Patients who received a defunctioning ileostomy during surgery were compared with those who did not. Outcomes included chronic kidney failure, chronic kidney disease, acute kidney injury, and dehydration. Cox proportional hazards models were fitted for each outcome, using overlap weights derived from propensity scores for receiving a defunctioning ileostomy. Stoma reversal impact and mediation by anastomotic leakage were also examined.

Results

Among 5286 patients, 4623 (87%) received a defunctioning ileostomy and 663 (13%) did not. A defunctioning ileostomy was not significantly associated with chronic kidney failure (HR 1.68, 95% CI: 0.19–15.16) or chronic kidney disease (HR 1.65, 95% CI: 0.91–2.98) but increased risks of acute kidney injury (HR 3.01, 95% CI: 1.61–5.64) and dehydration (HR 4.02, 95% CI: 2.33–6.94). Risks declined after stoma reversal. Stomas reduced anastomotic leakage with negligible mediation effects on short-term kidney damage.

Conclusion

A defunctioning ileostomy after low anterior resection increases the risks of acute kidney injury and dehydration but not chronic kidney failure or chronic kidney disease. These risks decrease following stoma reversal, highlighting the need for careful perioperative management.

目的:探讨直肠癌低位前切除术患者的短期和长期肾损伤发生率,并与未行回肠造口术的患者进行比较。方法:我们选取了所有年龄≤80岁,ASA健康等级≤III,肿瘤高度距肛门边缘≤12 cm的瑞典直肠癌患者,这些患者在2007年至2021年间使用CRCBaSe(一个全国性的登记链接)进行了前切除术。在手术中接受失功能回肠造口术的患者与未接受的患者进行了比较。结果包括慢性肾衰竭、慢性肾病、急性肾损伤和脱水。Cox比例风险模型对每个结果进行拟合,使用由接受失功能回肠造口的倾向评分得出的重叠权重。吻合口漏对造口逆转的影响和调解作用也进行了研究。结果:在5286例患者中,4623例(87%)接受了功能性回肠造口术,663例(13%)没有。失功能回肠造口术与慢性肾衰竭(HR 1.68, 95% CI: 0.19-15.16)或慢性肾脏疾病(HR 1.65, 95% CI: 0.91-2.98)无显著相关性,但会增加急性肾损伤(HR 3.01, 95% CI: 1.61-5.64)和脱水(HR 4.02, 95% CI: 2.33-6.94)的风险。造口逆转后风险降低。吻合口减少吻合口漏,对短期肾损害的调解作用可忽略不计。结论:低位前切除术后失功能回肠造口术会增加急性肾损伤和脱水的风险,但不会增加慢性肾衰竭或慢性肾脏疾病的风险。这些风险在造口逆转后降低,强调需要仔细的围手术期管理。
{"title":"The impact of defunctioning ileostomies on postoperative kidney function in rectal cancer surgery","authors":"Gustav Sandén,&nbsp;Ida Hed Myrberg,&nbsp;Sol Erika Boman,&nbsp;Caroline Nordenvall,&nbsp;Juan-Jesus Carrero,&nbsp;Peter Matthiessen,&nbsp;Martin Rutegård","doi":"10.1111/codi.70329","DOIUrl":"10.1111/codi.70329","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To investigate short- and long-term kidney injury incidence in patients undergoing low anterior resection for rectal cancer, comparing those with and without a defunctioning ileostomy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>We identified all Swedish rectal cancer patients ≤80 years old, with ASA fitness grade ≤III and tumour height ≤12 cm from the anal verge, who underwent anterior resection between 2007 and 2021 using CRCBaSe, a nationwide registry linkage. Patients who received a defunctioning ileostomy during surgery were compared with those who did not. Outcomes included chronic kidney failure, chronic kidney disease, acute kidney injury, and dehydration. Cox proportional hazards models were fitted for each outcome, using overlap weights derived from propensity scores for receiving a defunctioning ileostomy. Stoma reversal impact and mediation by anastomotic leakage were also examined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 5286 patients, 4623 (87%) received a defunctioning ileostomy and 663 (13%) did not. A defunctioning ileostomy was not significantly associated with chronic kidney failure (HR 1.68, 95% CI: 0.19–15.16) or chronic kidney disease (HR 1.65, 95% CI: 0.91–2.98) but increased risks of acute kidney injury (HR 3.01, 95% CI: 1.61–5.64) and dehydration (HR 4.02, 95% CI: 2.33–6.94). Risks declined after stoma reversal. Stomas reduced anastomotic leakage with negligible mediation effects on short-term kidney damage.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>A defunctioning ileostomy after low anterior resection increases the risks of acute kidney injury and dehydration but not chronic kidney failure or chronic kidney disease. These risks decrease following stoma reversal, highlighting the need for careful perioperative management.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12685789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High versus low take-off rectal prolapse: Outcomes of tailored surgery 高起飞与低起飞直肠脱垂:定制手术的结果。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-08 DOI: 10.1111/codi.70330
Mohit Satish Gupta, Usman Mateen, Nicola Davies, Andrew Clarke

Background

Full-thickness rectal prolapse (FTRP) is heterogeneous, with outcomes varying despite similar anatomy. Cooper et al. proposed a radiological classification based on prolapse ‘take-off’ level on defecating proctography (DPG), hypothesising that high take-off (HTO) and low take-off (LTO) phenotypes may respond differently to abdominal versus perineal repair. This hypothesis has not previously been tested in a clinical cohort.

Methods

A retrospective observational cohort study was performed across three hospitals over 12 years (2012–2024). Patients undergoing laparoscopic ventral mesh rectopexy (VMR), as first standardised by D'Hoore et al. [3] or Delorme's procedure with DPG-defined take-off were included. Outcomes were compared between procedures, matched versus unmatched surgery, and HTO versus LTO. The primary end-point was anatomical recurrence. Secondary end-points included radiological findings and symptom profiles by phenotype.

Results

Of 108 patients, 71 (52 VMR, 19 Delorme's) had evaluable DPG and were included in phenotype analysis (HTO, n = 28; LTO, n = 43). Overall recurrence was 15.5%. Recurrence was lower after VMR than Delorme's (13.5% vs. 21.1%, p = 0.47) and in matched versus unmatched surgery (12.8% vs. 20.8%, p = 0.53), though not statistically significant. Within VMR, recurrence was lower in HTO than LTO (8.3% vs. 17.9%). HTO was significantly associated with enterocele (71.4% vs. 44.2%, p = 0.030) and greater perineal discomfort (85.7% vs. 55.8%, p = 0.010), whereas LTO more frequently presented with incontinence/urgency.

Conclusion

This first clinical validation of the high/low take-off concept demonstrates phenotype-specific differences in radiology, symptoms, and surgical outcomes. Tailoring surgery to prolapse phenotype may reduce recurrence and guide personalised operative planning. Prospective, multicentre studies with quality-of-life outcomes are warranted.

背景:全层直肠脱垂(FTRP)是异质性的,尽管解剖结构相似,但其结果却不同。Cooper等人提出了一种基于排便直肠造影(DPG)脱垂“起飞”水平的放射学分类,假设高起飞(HTO)和低起飞(LTO)表型对腹部和会阴修复的反应可能不同。这一假设此前尚未在临床队列中得到验证。方法:回顾性观察队列研究在三家医院进行了12年(2012-2024)。接受腹腔镜腹侧网状直肠固定术(VMR)的患者,首先由D'Hoore等人标准化,b[3]或Delorme的手术与dpg定义的起飞。结果比较了手术过程、匹配手术与不匹配手术、HTO与LTO。主要终点为解剖性复发。次要终点包括放射学表现和表型的症状概况。结果:108例患者中,71例(52例VMR, 19例Delorme’s)具有可评估的DPG,并纳入表型分析(HTO, n = 28; LTO, n = 43)。总复发率为15.5%。VMR术后复发率低于Delorme术后(13.5% vs. 21.1%, p = 0.47),匹配手术vs.不匹配手术(12.8% vs. 20.8%, p = 0.53),但无统计学意义。在VMR中,HTO的复发率低于LTO (8.3% vs. 17.9%)。HTO与小肠膨出(71.4%比44.2%,p = 0.030)和会阴不适(85.7%比55.8%,p = 0.010)显著相关,而LTO更常表现为尿失禁/尿急。结论:高/低起飞概念的首次临床验证证明了放射学、症状和手术结果的表型特异性差异。根据脱垂表型定制手术可以减少复发并指导个性化的手术计划。具有生活质量结果的前瞻性、多中心研究是有必要的。
{"title":"High versus low take-off rectal prolapse: Outcomes of tailored surgery","authors":"Mohit Satish Gupta,&nbsp;Usman Mateen,&nbsp;Nicola Davies,&nbsp;Andrew Clarke","doi":"10.1111/codi.70330","DOIUrl":"10.1111/codi.70330","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Full-thickness rectal prolapse (FTRP) is heterogeneous, with outcomes varying despite similar anatomy. Cooper et al. proposed a radiological classification based on prolapse ‘take-off’ level on defecating proctography (DPG), hypothesising that high take-off (HTO) and low take-off (LTO) phenotypes may respond differently to abdominal versus perineal repair. This hypothesis has not previously been tested in a clinical cohort.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective observational cohort study was performed across three hospitals over 12 years (2012–2024). Patients undergoing laparoscopic ventral mesh rectopexy (VMR), as first standardised by D'Hoore et al. [3] or Delorme's procedure with DPG-defined take-off were included. Outcomes were compared between procedures, matched versus unmatched surgery, and HTO versus LTO. The primary end-point was anatomical recurrence. Secondary end-points included radiological findings and symptom profiles by phenotype.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 108 patients, 71 (52 VMR, 19 Delorme's) had evaluable DPG and were included in phenotype analysis (HTO, <i>n</i> = 28; LTO, <i>n</i> = 43). Overall recurrence was 15.5%. Recurrence was lower after VMR than Delorme's (13.5% vs. 21.1%, <i>p</i> = 0.47) and in matched versus unmatched surgery (12.8% vs. 20.8%, <i>p</i> = 0.53), though not statistically significant. Within VMR, recurrence was lower in HTO than LTO (8.3% vs. 17.9%). HTO was significantly associated with enterocele (71.4% vs. 44.2%, <i>p</i> = 0.030) and greater perineal discomfort (85.7% vs. 55.8%, <i>p</i> = 0.010), whereas LTO more frequently presented with incontinence/urgency.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This first clinical validation of the high/low take-off concept demonstrates phenotype-specific differences in radiology, symptoms, and surgical outcomes. Tailoring surgery to prolapse phenotype may reduce recurrence and guide personalised operative planning. Prospective, multicentre studies with quality-of-life outcomes are warranted.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to ‘PAVFCOS: The development of a core outcome set for pouch anal and vaginal fistula’ 对“PAVFCOS:开发一套治疗肛瘘和阴道瘘的核心结果”的修正。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-04 DOI: 10.1111/codi.70334

Reza L, Bapir L, Iqbal N, Sackitey C, Hughes S, Babbar M, et al. PAVFCOS: the development of a core outcome set for pouch anal and vaginal fistula. Colorectal Dis. 2025;27(8):e70184. https://doi.org/10.1111/codi.70184

In the Appendix section, listing all the ‘Collaborators’, Tricia Levasseur's name has now been added, as it was omitted from the original article.

We apologize for this error.

Reza L, Bapir L, Iqbal N, Sackitey C, Hughes S, Babbar M,等。PAVFCOS:一个核心结果集的发展肛瘘和阴道瘘管。大肠癌杂志,2025;27(8):e70184。https://doi.org/10.1111/codi.70184In附录部分,列出了所有的“合作者”,Tricia Levasseur的名字现在已经被添加,因为它从原始文章中被省略了。我们为这个错误道歉。
{"title":"Correction to ‘PAVFCOS: The development of a core outcome set for pouch anal and vaginal fistula’","authors":"","doi":"10.1111/codi.70334","DOIUrl":"10.1111/codi.70334","url":null,"abstract":"<p>Reza L, Bapir L, Iqbal N, Sackitey C, Hughes S, Babbar M, et al. PAVFCOS: the development of a core outcome set for pouch anal and vaginal fistula. Colorectal Dis. 2025;27(8):e70184. https://doi.org/10.1111/codi.70184</p><p>In the Appendix section, listing all the ‘Collaborators’, Tricia Levasseur's name has now been added, as it was omitted from the original article.</p><p>We apologize for this error.</p>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/codi.70334","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The diagnostic value of faecal calprotectin levels in patients with perianal fistula: A systematic review 粪钙保护蛋白水平在肛瘘患者中的诊断价值:一项系统综述。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-04 DOI: 10.1111/codi.70331
Stavros Chatziisaak, Pascal Burri, Sebastian Wolf, Moritz Sparn, Dieter Hahnloser, Stephan Bischofberger, Dimitrios Chatziisaak

Aim

Perianal fistula (PAF) is a common condition encountered in surgical and gastroenterological practice. Distinguishing between cryptoglandular disease (CGD) and inflammatory bowel disease (IBD)-related perianal disease is critical to ensure appropriate management. Faecal calprotectin (FC) has emerged as a promising non-invasive biomarker for IBD; however, its role in acute perianal disease is not well established. This systematic review aimed to evaluate the diagnostic accuracy of FC in distinguishing IBD-related perianal disease from CGD.

Method

A systematic literature search was conducted in PubMed, Embase and Cochrane databases following PRISMA guidelines. Studies were included if they assessed FC levels in patients with PAF and provided diagnostic accuracy metrics. Data extraction focused on study design, population characteristics, FC cut-off values, sensitivity, specificity and area under the curve (AUC) metrics.

Results

Three studies met the inclusion criteria, all reporting significantly higher FC levels in IBD-related PAF compared to CGD-related fistulas. The proposed FC cut-off values varied, ranging from 110 μg/g to 344 μg/g, with corresponding sensitivities between 52% and 81%, as well as specificities between 77% and 93%. The AUC values indicated moderate to high diagnostic accuracy.

Conclusion

FC shows potential as a diagnostic tool for differentiating IBD-related perianal disease from CGD. A cut-off of 110–150 μg/g appears most suitable for early screening, whereas a higher threshold may be appropriate for confirmatory diagnosis. Further prospective studies with standardized protocols are necessary to refine these thresholds and validate FC as a clinical decision-making tool.

目的:肛周瘘(PAF)是外科和胃肠病学实践中常见的疾病。区分隐腺病(CGD)和炎症性肠病(IBD)相关肛周疾病是确保适当治疗的关键。粪钙保护蛋白(FC)已成为一种很有前途的IBD非侵入性生物标志物;然而,其在急性肛周疾病中的作用尚未得到很好的确定。本系统综述旨在评估FC在区分ibd相关肛周疾病和CGD中的诊断准确性。方法:系统检索PubMed、Embase和Cochrane数据库,按照PRISMA指南进行文献检索。如果研究评估PAF患者的FC水平并提供诊断准确性指标,则纳入研究。数据提取侧重于研究设计、人群特征、FC截止值、敏感性、特异性和曲线下面积(AUC)指标。结果:3项研究符合纳入标准,均报告ibd相关PAF中FC水平明显高于cgd相关瘘管。提出的FC截止值范围为110 ~ 344 μg/g,相应的灵敏度为52% ~ 81%,特异性为77% ~ 93%。AUC值显示中等至较高的诊断准确性。结论:FC可作为ibd相关肛周疾病与CGD的鉴别诊断工具。110-150 μg/g的临界值似乎最适合早期筛查,而更高的临界值可能适合确诊。有必要采用标准化方案进行进一步的前瞻性研究,以完善这些阈值并验证FC作为临床决策工具。
{"title":"The diagnostic value of faecal calprotectin levels in patients with perianal fistula: A systematic review","authors":"Stavros Chatziisaak,&nbsp;Pascal Burri,&nbsp;Sebastian Wolf,&nbsp;Moritz Sparn,&nbsp;Dieter Hahnloser,&nbsp;Stephan Bischofberger,&nbsp;Dimitrios Chatziisaak","doi":"10.1111/codi.70331","DOIUrl":"10.1111/codi.70331","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>Perianal fistula (PAF) is a common condition encountered in surgical and gastroenterological practice. Distinguishing between cryptoglandular disease (CGD) and inflammatory bowel disease (IBD)-related perianal disease is critical to ensure appropriate management. Faecal calprotectin (FC) has emerged as a promising non-invasive biomarker for IBD; however, its role in acute perianal disease is not well established. This systematic review aimed to evaluate the diagnostic accuracy of FC in distinguishing IBD-related perianal disease from CGD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>A systematic literature search was conducted in PubMed, Embase and Cochrane databases following PRISMA guidelines. Studies were included if they assessed FC levels in patients with PAF and provided diagnostic accuracy metrics. Data extraction focused on study design, population characteristics, FC cut-off values, sensitivity, specificity and area under the curve (AUC) metrics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Three studies met the inclusion criteria, all reporting significantly higher FC levels in IBD-related PAF compared to CGD-related fistulas. The proposed FC cut-off values varied, ranging from 110 μg/g to 344 μg/g, with corresponding sensitivities between 52% and 81%, as well as specificities between 77% and 93%. The AUC values indicated moderate to high diagnostic accuracy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>FC shows potential as a diagnostic tool for differentiating IBD-related perianal disease from CGD. A cut-off of 110–150 μg/g appears most suitable for early screening, whereas a higher threshold may be appropriate for confirmatory diagnosis. Further prospective studies with standardized protocols are necessary to refine these thresholds and validate FC as a clinical decision-making tool.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic impact of lymph node yield in deficient and proficient mismatch repair colon cancers: A retrospective national cohort study 缺乏和熟练错配修复结肠癌的淋巴结产量对预后的影响:一项回顾性国家队列研究。
IF 2.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-12-03 DOI: 10.1111/codi.70332
Frederik W. Bækgaard, Anisoara Iordache, Andreas Hurup Nordholm, Peter-Martin Krarup, Nis Hallundbæk Schlesinger, Camilla Qvortrup, Henry G. Smith

Introduction

Lymph node yield (LNY) is a recognised prognostic factor in patients with colon cancer. Recent studies suggest LNY may reflect anti-tumour immune responses rather than surgical quality. Given the recognised difference in anti-tumour immunity according to mismatch repair (MMR) status, this study investigated whether LNY and its association with prognosis differed between colon cancers with deficient MMR (dMMR) and proficient MMR (pMMR).

Methods

A national retrospective cohort study using the Danish Colorectal Cancer Group (DCCG) database. Patients diagnosed with new Stage I–III colon cancers undergoing potentially curative left or right hemicolectomies between 2016 and 2022 were included. The primary outcome was LNY according to MMR status.

Results

In total of 9705 patients were included, of whom 7175 had pMMR cancers (74%). Median LNY for the whole cohort was 27. LNY <12 was seen in 178 patients (2%). dMMR cancers had higher median LNY (28 vs. 26 nodes, p < 0.001), and more patients with LNY ≥22 (73% vs. 66%, p < 0.001). No difference in the number of lymph node metastases was seen between groups. LNY <12 was associated with poorer overall survival (OS) regardless of MMR status and was independently associated with all-cause mortality. However, this effect was more marked in patients with dMMR than pMMR cancers {hazard ratio (HR) 4.23 (95% confidence interval [CI] 2.42–7.41) vs. 1.94 (1.21–3.13)}.

Conclusion

LNY was significantly higher in dMMR cancers, where low LNY also has a stronger association with prognosis. These findings support the theory that LNY reflects anti-tumour immunity rather than surgical quality.

导言:淋巴结产量(LNY)是结肠癌患者公认的预后因素。最近的研究表明,LNY可能反映的是抗肿瘤免疫反应,而不是手术质量。考虑到根据错配修复(MMR)状态的抗肿瘤免疫的公认差异,本研究调查了MMR缺陷(dMMR)和MMR熟练(pMMR)结肠癌之间LNY及其与预后的关系是否存在差异。方法:使用丹麦结直肠癌组(DCCG)数据库进行全国性回顾性队列研究。在2016年至2022年期间接受可能治愈的左半结肠或右半结肠切除术的新I-III期结肠癌患者被纳入研究。根据MMR状态,主要结局为LNY。结果:共纳入9705例患者,其中7175例为pMMR癌(74%)。整个队列的平均寿命为27岁。结论:LNY在dMMR肿瘤中显著升高,低LNY与预后也有较强的相关性。这些发现支持LNY反映抗肿瘤免疫而不是手术质量的理论。
{"title":"The prognostic impact of lymph node yield in deficient and proficient mismatch repair colon cancers: A retrospective national cohort study","authors":"Frederik W. Bækgaard,&nbsp;Anisoara Iordache,&nbsp;Andreas Hurup Nordholm,&nbsp;Peter-Martin Krarup,&nbsp;Nis Hallundbæk Schlesinger,&nbsp;Camilla Qvortrup,&nbsp;Henry G. Smith","doi":"10.1111/codi.70332","DOIUrl":"10.1111/codi.70332","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Lymph node yield (LNY) is a recognised prognostic factor in patients with colon cancer. Recent studies suggest LNY may reflect anti-tumour immune responses rather than surgical quality. Given the recognised difference in anti-tumour immunity according to mismatch repair (MMR) status, this study investigated whether LNY and its association with prognosis differed between colon cancers with deficient MMR (dMMR) and proficient MMR (pMMR).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A national retrospective cohort study using the Danish Colorectal Cancer Group (DCCG) database. Patients diagnosed with new Stage I–III colon cancers undergoing potentially curative left or right hemicolectomies between 2016 and 2022 were included. The primary outcome was LNY according to MMR status.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In total of 9705 patients were included, of whom 7175 had pMMR cancers (74%). Median LNY for the whole cohort was 27. LNY &lt;12 was seen in 178 patients (2%). dMMR cancers had higher median LNY (28 vs. 26 nodes, <i>p</i> &lt; 0.001), and more patients with LNY ≥22 (73% vs. 66%, <i>p</i> &lt; 0.001). No difference in the number of lymph node metastases was seen between groups. LNY &lt;12 was associated with poorer overall survival (OS) regardless of MMR status and was independently associated with all-cause mortality. However, this effect was more marked in patients with dMMR than pMMR cancers {hazard ratio (HR) 4.23 (95% confidence interval [CI] 2.42–7.41) vs. 1.94 (1.21–3.13)}.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>LNY was significantly higher in dMMR cancers, where low LNY also has a stronger association with prognosis. These findings support the theory that LNY reflects anti-tumour immunity rather than surgical quality.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10512,"journal":{"name":"Colorectal Disease","volume":"27 12","pages":""},"PeriodicalIF":2.7,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145667475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colorectal Disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1